{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:43:14Z","timestamp":1790847794451,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.semarthrit.2005.12.004","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T11:07:13Z","timestamp":1144408033000},"page":"312-321","source":"Crossref","is-referenced-by-count":97,"title":["Atypical Autoantibodies in Patients with Primary Sj\u00f6gren Syndrome: Clinical Characteristics and Follow-Up of 82 Cases"],"prefix":"10.1016","volume":"35","author":[{"given":"Manuel","family":"Ramos-Casals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sira","family":"Aguil\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2005.12.004_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0889-857X(21)00317-3","article-title":"Salivary and oral components of Sjogren\u2019s syndrome","volume":"18","author":"Daniels","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sjogren\u2019s syndrome","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib4","first-page":"270","article-title":"Primary Sjogren syndrome","volume":"81","author":"Garcia-Carrasco","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","article-title":"Primary Sjogren syndrome","volume":"81","author":"Ramos-Casals","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sjogren\u2019s syndrome","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/0961203304lu1006oa","article-title":"Antiphospholipid antibodies in primary Sjogren\u2019s syndrome","volume":"13","author":"Fauchais","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib9","first-page":"361","article-title":"Antiphospholipid antibodies in primary Sjogren\u2019s syndrome","volume":"15","author":"Cervera","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/096120339500400106","article-title":"Primary Sj\u00f6gren syndrome preceding systemic lupus erythematosus","volume":"4","author":"Zufferey","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/096120339500400113","article-title":"Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren\u2019s syndrome","volume":"4","author":"Satoh","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","article-title":"Clusters of clinical and immunologic features in systemic lupus erythematosus","volume":"33","author":"Font","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/rheumatology\/37.12.1287","article-title":"Antineutrophil cytoplasmic antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"37","author":"Font","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.46.1.1","article-title":"Anticardiolipin antibodies","volume":"46","author":"Ghavari","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0038-1649988","article-title":"Laboratory identification of lupus anticoagulants","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib19","series-title":"Mixed connective tissue disease and anti-nuclear antibodies","first-page":"33","article-title":"Classification and diagnostic criteria for mixed connective tissue disease","author":"Alarcon-Segovia","year":"1987"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0090-1229(87)90073-0","article-title":"Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients","volume":"44","author":"Manoussakis","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.1780301013","article-title":"An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies","volume":"30","author":"Ingram","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.semarthrit.2005.12.004_bib24","article-title":"Anticardiolipin antibodies in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Arroyo","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib25","first-page":"165","article-title":"Serial measurements of anticardiolipin antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Pennec","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ard.51.4.495","article-title":"Antiphospholipid antibodies and HLA associations in primary Sjogren\u2019s syndrome","volume":"51","author":"Asherson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.51.7.889","article-title":"Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren\u2019s syndrome","volume":"51","author":"Jedryka-Goral","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2169\/internalmedicine.33.768","article-title":"Pulmonary hypertension and antiphospholipid antibody in a patient with Sjogren\u2019s syndrome","volume":"33","author":"Biyajima","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9343(96)00335-X","article-title":"The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases","volume":"101","author":"Merkel","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2169\/internalmedicine.39.73","article-title":"Sjogren\u2019s syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome","volume":"39","author":"Katayama","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sjogren\u2019s syndrome associated with systemic lupus erythematosus","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009749309095103","article-title":"Relationship between autoantibodies and clinical parameters in Sjogren\u2019s syndrome","volume":"22","author":"Tsuzaka","year":"1993","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib33","first-page":"339","article-title":"Sjogren\u2019s syndrome and mixed connective tissue disease","volume":"10","author":"Ohtsuka","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s100670070030","article-title":"Clinical and serological aspects of patients with anti-Jo-1 antibodies","volume":"19","author":"Schmidt","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0272-6386(12)80876-6","article-title":"Antineutrophil cytoplasmic autoantibody-associated diseases","volume":"18","author":"Gross","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/00016489409128333","article-title":"Diagnostic specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in otorhinolaryngological diseases","volume":"511","author":"Fukase","year":"1994","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib37","first-page":"573","article-title":"[Clinical analysis of 14 patients with anti-myeloperoxidase antibody positive rapid progressive glomerulonephritic syndrome]","volume":"37","author":"Hiromura","year":"1995","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib38","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/oxfordjournals.ndt.a027157","article-title":"ANCA-associated pauci-immune crescentic glomerulonephritis complicating Sjogren\u2019s syndrome","volume":"11","author":"Hernandez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib39","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease","volume":"126","author":"Merkel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s100670050100","article-title":"Antineutrophil cytoplasmic antibody in patients with primary Sjogren\u2019s syndrome","volume":"18","author":"Nishiya","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ndt\/14.4.1033","article-title":"Sjogren\u2019s syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis","volume":"14","author":"Kamachi","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000045843","article-title":"Crescentic glomerulonephritis and primary Sjogren\u2019s syndrome","volume":"86","author":"Tatsumi","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib43","first-page":"1647","article-title":"[Rapidly progressive acute renal failure. A rare complication of primary Sjogren syndrome]","volume":"29","author":"Akposso","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/030097400750041442","article-title":"Sjogren\u2019s syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3","volume":"29","author":"Young","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib45","first-page":"362","article-title":"Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma","volume":"64","author":"Tubach","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/38.9.826","article-title":"Microvascular abnormalities in Sjogren\u2019s syndrome","volume":"38","author":"Tektonidou","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib47","first-page":"785","article-title":"Sj\u00f6gren\u2019s syndrome with anticentromere antibodies","volume":"64","author":"Caramaschi","year":"1997","journal-title":"Rev Rhum (Engl Ed)"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies (ACA)","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib49","first-page":"2238","article-title":"Clinical and laboratory features of anticentromere antibody positive primary Sjogren\u2019s syndrome","volume":"28","author":"Katano","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/art.20094","article-title":"Systemic lupus erythematosus and Sjogren\u2019s syndrome","volume":"50","author":"Isenberg","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib51","first-page":"723","article-title":"SLE in the elderly\u2014is it really SLE or systemic Sjogren\u2019s syndrome?","volume":"15","author":"Bell","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","article-title":"Cutaneous vasculitis in primary Sjogren syndrome","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren\u2019s syndrome","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib56","first-page":"437","article-title":"Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus","volume":"20","author":"Perez-Vazquez","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10067-002-0657-2","article-title":"Antitopoisomerase I antibody in patients with systemic lupus erythematosus\/sicca syndrome without a concomitant scleroderma","volume":"22","author":"Al Attia","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib58","first-page":"840","article-title":"[Autoimmune hepatitis, acute pancreatitis, mixed connective tissue disease and Sjogren\u2019s syndrome. A case report.]","volume":"27","author":"Kmieciak","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib59","first-page":"80","article-title":"Co-occurrence of spondyloarthropathy and connective tissue disease","volume":"20","author":"Brandt","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib60","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3346\/jkms.2001.16.4.512","article-title":"A case of cholestatic autoimmune hepatitis and acute liver failure","volume":"16","author":"Min","year":"2001","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.semarthrit.2005.12.004_bib61","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00042737-199908000-00022","article-title":"Acute self-limiting jejunitis as the first manifestation of microscopic polyangiitis associated with Sjogren\u2019s disease","volume":"11","author":"Radaelli","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901720500243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901720500243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T12:13:58Z","timestamp":1627215238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901720500243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S004901720500243X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2005.12.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}